Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Title Grant Number Sort descending Program Official
Fuschiotti, Patrizia

University Of Pittsburgh At Pittsburgh
United States

Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides 5R21CA280445-02 Wendy Wang, Ph.D., M.Sc.
Alambeigi, Farshid

University Of Texas At Austin
United States

A Novel Framework for Sensitive and Reliable Early Diagnosis, Topographic Mapping, and Stiffness Classification of Colorectal Cancer Polyps 5R21CA280747-02 Matthew Young, Ph.D.
Pozdeyev, Nikita

University Of Colorado Denver
United States

Genetic architecture of thyroid cancer and its clinical utility 5R21CA282380-02 Wendy Wang, Ph.D., M.Sc.
Li, Feng

University Of California Los Angeles
United States

Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer. 5R21CA283665-02 Guillermo Marquez, Ph.D.
Lesch, Bluma J

Yale University
United States

Defining signatures of epigenetic sensitization to lung cancer in a mouse model 5R21CA288677-02 Guillermo Marquez, Ph.D.
Webster, Nicholas J

Veterans Medical Research Fdn/San Diego
United States

The Effect of Time-Restricted Eating on the Efficiency of Chemo- and Hormonal-Therapy in Breast Cancer 5R21CA288777-02 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Grossman, Douglas

Utah State Higher Education System--University Of Utah
United States

Electrical impedance dermography as a biomarker for basal and squamous cell carcinoma 5R21CA289101-02 Nicholas Hodges, Ph.D.
Burgess, Mark Thomas

Sloan-Kettering Inst Can Research
United States

Clinical assessment of radiotherapy-induced vaginal toxicity with multiparametric ultrasound imaging 5R21CA290252-02 Goli Samimi, Ph.D., M.P.H.
Song, Ming

University Of Louisville
United States

Dietary fructose and NASH/HCC progression 5R21CA290420-02 Amit Kumar, Ph.D.
Damaj, M. Imad

Virginia Commonwealth University
United States

Inhibition of NLRP3 inflammasome for the treatment of Chemotherapy-induced peripheral neuropathy 5R21CA296516-02 Rachel Altshuler, Ph.D.